Literature DB >> 22167569

Drug burden index, physical function, and adverse outcomes in older hospitalized patients.

Estelle Lowry1, Richard J Woodman, Roy L Soiza, Sarah N Hilmer, Arduino A Mangoni.   

Abstract

The Drug Burden Index (DBI) is associated with poorer physical function in stable, community-dwelling, older people. The authors speculated that a higher DBI is associated with reduced physical function (Barthel Index, primary outcome) and predicts adverse outcomes (length of stay, in-hospital mortality, secondary outcomes) in frail, acutely ill, older hospitalized patients. Clinical and demographic characteristics, Barthel Index, DBI, and full medication exposure were recorded on admission in 362 consecutive patients (84 ± 7 years old) admitted to 2 acute geriatric units between February 1, 2010, and June 30, 2010. A unit increase in DBI was associated with a 29% reduction in the odds of being in a higher Barthel Index quartile than a lower quartile (odds ratio, 0.71; 95% confidence interval, 0.55-0.91; P = .007). The Barthel Index components mostly affected were bathing (P < .001), grooming (P < .001), dressing (P = .001), bladder function (P < .001), transfers (P = .001), mobility (P < .001), and stairs (P < .001). A higher DBI independently predicted length of stay (hazard ratio, 1.23; 95% confidence interval, 1.06-1.42; P = .005) but not in-hospital mortality (hazard ratio, 1.17; 95% confidence interval, 0.72-1.90; P = .52). Higher DBI scores on admission are independently associated with lower scores of the Barthel Index and predict length of stay among older hospitalized patients. The DBI may be useful in the acute setting to improve risk stratification.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22167569     DOI: 10.1177/0091270011421489

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  36 in total

1.  Drug Burden Index and hospitalization among community-dwelling older people.

Authors:  Eija Lönnroos; Danijela Gnjidic; Sarah N Hilmer; J Simon Bell; Hannu Kautiainen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

2.  Central Anticholinergic Adverse Effects and Their Measurement.

Authors:  Pasi Lampela; Teemu Paajanen; Sirpa Hartikainen; Risto Huupponen
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

3.  Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.

Authors:  V Boccardi; M Baroni; L Paolacci; S Ercolani; A Longo; M Giordano; C Ruggiero; P Mecocci
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

4.  Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews.

Authors:  Tomas J Welsh; Veronika van der Wardt; Grace Ojo; Adam L Gordon; John R F Gladman
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

5.  The Association Between Drug Burden Index (DBI) and Health-Related Outcomes: A Longitudinal Study of the 'Oldest Old' (LiLACS NZ).

Authors:  Karen Cardwell; Ngaire Kerse; Cristín Ryan; Ruth Teh; Simon A Moyes; Oliver Menzies; Anna Rolleston; Joanna Broad; Carmel M Hughes
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

6.  Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study.

Authors:  Hamish A Jamieson; Prasad S Nishtala; Richard Scrase; Joanne M Deely; Rebecca Abey-Nesbit; Martin J Connolly; Sarah N Hilmer; Darrell R Abernethy; Philip J Schluter
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

7.  Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients.

Authors:  Clare V Bostock; Roy L Soiza; Arduino A Mangoni
Journal:  Ther Adv Drug Saf       Date:  2013-12

Review 8.  Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?

Authors:  Tanja Mayer; Walter E Haefeli; Hanna M Seidling
Journal:  Eur J Clin Pharmacol       Date:  2015-09-08       Impact factor: 2.953

9.  Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.

Authors:  Kimberley Ruxton; Richard J Woodman; Arduino A Mangoni
Journal:  Br J Clin Pharmacol       Date:  2015-05-20       Impact factor: 4.335

10.  Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycle.

Authors:  Hui Sian Tay; Roy L Soiza; Arduino A Mangoni
Journal:  Ther Adv Drug Saf       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.